Normobaric Oxygen in AIS Transferred for EVT

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

Also called NCT06666764

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06666764
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06666764. Randomized; single masking; primary purpose treatment. Start 2024-12-13 (actual); primary completion 2027-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Normobaric Oxygen in AIS Transferred for EVT
Acronym
AN-O2
Intervention (Other)
NBO
Intervention (Other)
Control
Lead sponsor
Capital Medical University (class: other)

Record details

Record id
cardio:ct-nct06666764
Content hash
1bcfe01c2e2390bfde0f6cfac08da1825f592eb7d5fc92fdab471389213357dc